{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:41:38Z","timestamp":1785512498585,"version":"3.56.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Parkinson disease (PD) is a progressive neurodegenerative disorder with highly variable progression rates. Accurate prediction of rapid disease progression is critical for patient management and clinical trial design. This study evaluates the use of machine learning (ML) models to predict rapid PD progression using integrated clinical and imaging biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 683 patients from the Parkinson\u2019s Progression Markers Initiative (PPMI). Mixed effects models for longitudinal data were used to determine PD progression rates, with rapid progression of PD (RPPD) defined as exceeding the cohort mean rate of change in either the Movement Disorder Society\u2019s Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS) total score or the lowest Putamen-Specific Binding ratio (SBR) on I-123 Ioflupane single photon emission tomography (SPECT). The minimum redundancy maximum relevance (MRMR) algorithm identified the most predictive features from a total of 123 features. Support vector machines (SVM) and decision tree (DT) models were trained and evaluated using 5-fold cross-validation and receiver operating characteristic area under the curve (ROC AUC) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 193 patients (135 males and 68 females) were included. The most predictive feature for RPPD was the lowest putamen SBR (MRMR score=0.44,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). The SVM model achieved an ROC AUC of 0.86 (95% CI: 0.78-0.91) using the 6 highest-ranked MRMR features, whereas the DT model, using only 2 clinically available features (UPDRS total score and lowest putamen SBR), achieved an ROC AUC of 0.81 (95% CI: 0.73-0.86).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Machine learning models, particularly SVM, demonstrate strong predictive performance in identifying rapid PD progression using multimodal clinical and imaging biomarkers. The integration of SPECT imaging with clinical assessments improves disease trajectory characterization, potentially supporting personalized treatment strategies and optimizing clinical trial design. Future studies should incorporate additional biomarkers and longer follow-up durations to enhance model generalizability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rct.0000000000001830","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T19:00:06Z","timestamp":1766602806000},"page":"471-480","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Machine Learning Prediction of Rapid Parkinson Disease Progression Using Combined Imaging and Clinical Biomarkers"],"prefix":"10.1097","volume":"50","author":[{"given":"Burcak","family":"Yilmaz","sequence":"first","affiliation":[{"name":"Department of Diagnostic Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, School of Medicine, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Szidonya","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir I.","family":"Yusufaly","sequence":"additional","affiliation":[{"name":"Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Panchal","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker","family":"Yaylali","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oregon Health and Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Litvan","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, University of California San Diego, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-7347","authenticated-orcid":false,"given":"Sebastian","family":"Obrzut","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/mds.27361","article-title":"Longitudinal change of clinical and biological measures in early Parkinson\u2019s disease: Parkinson\u2019s progression markers initiative cohort","volume":"33","author":"Simuni","year":"2018","journal-title":"Mov Disord"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"627199","DOI":"10.3389\/fnagi.2020.627199","article-title":"Motor progression in early-stage Parkinson\u2019s disease: a clinical prediction model and the role of cerebrospinal fluid biomarkers","volume":"12","author":"Ma","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson progression marker initiative (PPMI)","volume":"95","author":"Marek","year":"2011","journal-title":"Prog Neurobiol"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"The Parkinson\u2019s progression markers initiative (PPMI) \u2013 establishing a PD biomarker cohort","volume":"5","author":"Marek","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JPD-181518","article-title":"Predicting progression in Parkinson\u2019s disease using baseline and 1-year change measures","volume":"9","author":"Chahine","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"765765","DOI":"10.3389\/fnins.2021.765765","article-title":"Hoehn and Yahr stage and striatal Dat-SPECT uptake are predictors of Parkinson\u2019s disease motor progression","volume":"15","author":"Jackson","year":"2021","journal-title":"Front Neurosci"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JPD-191648","article-title":"The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson\u2019s disease","volume":"9","author":"Stephenson","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/cts.13508","article-title":"Associations of striatal dopamine transporter binding with motor and non-motor symptoms in early Parkinson\u2019s disease","volume":"16","author":"Yang","year":"2023","journal-title":"Clin Transl Sci"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"e0178982","DOI":"10.1371\/journal.pone.0178982","article-title":"A Bayesian mathematical model of motor and cognitive outcomes in Parkinson\u2019s disease","volume":"12","author":"Hayete","year":"2017","journal-title":"PLoS One"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.nicl.2017.08.021","article-title":"Improved prediction of outcome in Parkinson\u2019s disease using radiomics analysis of longitudinal DAT SPECT images","volume":"16","author":"Rahmim","year":"2017","journal-title":"Neuroimage Clin"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmp.2019.12.022","article-title":"Machine learning methods for optimal prediction of motor outcome in Parkinson\u2019s disease","volume":"69","author":"Salmanpour","year":"2020","journal-title":"Phys Med"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"104312","DOI":"10.1016\/j.compbiomed.2021.104312","article-title":"Improved motor outcome prediction in Parkinson\u2019s disease applying deep learning to DaTscan SPECT images","volume":"132","author":"Adams","year":"2021","journal-title":"Comput Biol Med"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"101807","DOI":"10.1016\/j.artmed.2020.101807","article-title":"Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson\u2019s disease","volume":"103","author":"Tsiouris","year":"2020","journal-title":"Artif Intell Med"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/mds.29519","article-title":"Predicting ambulatory capacity in Parkinson\u2019s disease to analyze progression, biomarkers, and trial design","volume":"38","author":"Venuto","year":"2023","journal-title":"Mov Disord"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JPD-230446","article-title":"Modeling of Parkinson\u2019s disease progression and implications for detection of disease modification in treatment trials","volume":"14","author":"Ribba","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"103347","DOI":"10.1016\/j.compbiomed.2019.103347","article-title":"Optimized machine learning methods for prediction of cognitive outcome in Parkinson\u2019s disease","volume":"111","author":"Salmanpour","year":"2019","journal-title":"Comput Biol Med"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s11307-019-01334-5","article-title":"Artificial neural network-based prediction of outcome in Parkinson\u2019s disease patients using DaTscan SPECT imaging features","volume":"21","author":"Tang","year":"2019","journal-title":"Mol Imaging Biol"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cts.12492","article-title":"Dopamine transporter neuroimaging as an enrichment biomarker in early Parkinson\u2019s disease clinical trials: a disease progression modeling analysis","volume":"11","author":"Conrado","year":"2018","journal-title":"Clin Transl Sci"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1474-4422(17)30328-9","article-title":"Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson\u2019s disease: a longitudinal cohort study and validation","volume":"16","author":"Latourelle","year":"2017","journal-title":"Lancet Neurol"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.parkreldis.2011.04.002","article-title":"Estimation of further disease progression of Parkinson\u2019s disease by dopamine transporter scan vs clinical rating","volume":"17","author":"Vogt","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"101986","DOI":"10.1016\/j.nicl.2019.101986","article-title":"Assessment of a prognostic MRI biomarker in early de novo Parkinson\u2019s disease","volume":"24","author":"Zeighami","year":"2019","journal-title":"Neuroimage Clin"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/mds.27806","article-title":"Longitudinal analyses of cerebrospinal fluid \u03b1-Synuclein in prodromal and early Parkinson\u2019s disease","volume":"34","author":"Mollenhauer","year":"2019","journal-title":"Mov Disord"},{"key":"R25-20260605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.parkreldis.2021.02.008","article-title":"Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson\u2019s disease: an 8-year longitudinal study","volume":"85","author":"Ye","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1142\/S0219720005001004","article-title":"Minimum redundancy feature selection from microarray gene expression data","volume":"3","author":"Ding","year":"2005","journal-title":"J Bioinform Comput Biol"},{"key":"R27-20260605","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0893-6080(03)00169-2","article-title":"Practical selection of SVM parameters and noise estimation for SVM regression","volume":"17","author":"Cherkassky","year":"2004","journal-title":"Neural Netw"},{"key":"R28-20260605","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jiph.2022.06.008","article-title":"Machine learning decision tree algorithm role for predicting mortality in critically ill adult COVID-19 patients admitted to the ICU","volume":"15","author":"Elhazmi","year":"2022","journal-title":"J Infect Public Health"},{"key":"R29-20260605","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/brainsci10020073","article-title":"Dynamical role of pivotal brain regions in Parkinson symptomatology uncovered with deep learning","volume":"10","author":"Nguyen","year":"2020","journal-title":"Brain Sci"},{"key":"R30-20260605","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/acn3.317","article-title":"Predictors of time to initiation of symptomatic therapy in early Parkinson\u2019s disease","volume":"3","author":"Simuni","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"R31-20260605","doi-asserted-by":"crossref","first-page":"371","DOI":"10.62347\/AICM8774","article-title":"PET, SPECT, and MRI imaging for evaluation of Parkinson\u2019s disease","volume":"14","author":"Gujral","year":"2024","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R32-20260605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","article-title":"Imaging biomarkers in Parkinson\u2019s disease and Parkinsonian syndromes: current and emerging concepts","volume":"6","author":"Saeed","year":"2017","journal-title":"Transl Neurodegener"},{"key":"R33-20260605","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41824-024-00232-6","article-title":"FDG-PET-based brain network analysis: a brief review of metabolic connectivity","volume":"9","author":"Tuan","year":"2025","journal-title":"EJNMMI Reports"},{"key":"R34-20260605","doi-asserted-by":"crossref","first-page":"e70047","DOI":"10.1002\/hbm.70047","article-title":"Cholinergic denervation patterns in Parkinson\u2019s disease associated with cognitive impairment across domains","volume":"46","author":"d'Angremont","year":"2025","journal-title":"Hum Brain Mapp"},{"key":"R35-20260605","first-page":"70048","article-title":"Age-disproportionate atrophy in Alzheimer\u2019s disease and Parkinson\u2019s disease spectra","volume":"17","author":"Yoshinaga","year":"2025","journal-title":"Alzheim Dement"},{"key":"R36-20260605","doi-asserted-by":"crossref","first-page":"107230","DOI":"10.1016\/j.parkreldis.2024.107230","article-title":"Structural and functional connectomics of the olfactory system in Parkinson\u2019s disease: a systematic review","volume":"132","author":"Ielo","year":"2025","journal-title":"Parkinsonism Relat Disord"},{"key":"R37-20260605","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/RCT.0000000000001720","article-title":"Different imaging evaluating performances between glymphatic system and motor symptoms and levodopa responsiveness of Parkinson disease","volume":"49","author":"Deng","year":"2025","journal-title":"J Comput Assist Tomogr"},{"key":"R38-20260605","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41531-024-00758-3","article-title":"A worldwide study of white matter microstructural alterations in people living with Parkinson\u2019s disease","volume":"10","author":"Owens-Walton","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"R39-20260605","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1474-4422(19)30319-9","article-title":"Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson\u2019s Progression Markers Initiative (PPMI): a cross-sectional study","volume":"19","author":"Simuni","year":"2020","journal-title":"Lancet Neurol"},{"key":"R40-20260605","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson\u2019s disease: a cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol"},{"key":"R41-20260605","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.nicl.2016.02.012","article-title":"Application of texture analysis to DAT SPECT imaging: relationship to clinical assessments","volume":"12","author":"Rahmim","year":"2016","journal-title":"Neuroimage Clin"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:00:13Z","timestamp":1780693213000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001830","relation":{},"ISSN":["1532-3145"],"issn-type":[{"value":"1532-3145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"2025-05-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}